| Tag | Content |
|---|
EnhancerAtlas ID | HS134-61925 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr9:15293860-15295600 |
SNPs | | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Sox3 | MA0514.1 | chr9:15294444-15294454 | AAAACAAAGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_12243 | chr9:15293120-15301548 | CD3 | | SE_18538 | chr9:15291529-15302017 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19786 | chr9:15293474-15301563 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_22766 | chr9:15292843-15301704 | CD8_primiary | | SE_29496 | chr9:15292911-15297917 | Fetal_Intestine_Large |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr9 | 15294977 | 15295134 | | chr9 | 15295224 | 15295550 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH09I015293 | chr9 | 15293063 | 15301280 |
|
Enhancer Sequence | GTTCAAATAA AGCAAACTGT GGGCTGTAAC CAATCCAGCT GTCTCTGTAC CTCACTTCCG 60
TTTTCTGCAC GTCACTTTCC TTTCTCTGTC CATAAATCTT CTTCCACCAC ATGGCTGCAC 120
TGCAGTCTCC GAGCCTGCTC TGGCTCCAGA GATCGACTGA TTCACGAATC TTTCATTGCT 180
CAATTGAACT CCTTTAAATT TAATTCTGCT GAAGTTTTTA TCATATGTCA TGCTAAGGTA 240
TTTGCATGTT ACTTTAAAGG CAATGAGAAG CTGTGCACAG ATTTTAAGAG GCAAGGCGAA 300
AATGGACTTG CATTTTAGAA AGAGCAGTCT ATTGTCAGCT GCTAGCAGCT GGAAAAAAAA 360
AAAGCAGTCT AGCGCAGTAC ACTGCTTTAG GGCACAGCAA GAACCCTAGA GTCCCTCCAG 420
GGCTCAGGAA TGCTTGCACA CTCTTACTTC CTTTACCTTT TAGCCTCTTA CGTTCAGTAA 480
CTGAACACAA ACATACCTTT TACAGGCCAT AGTCTCCTAC CAACATCTAG GTGCTACCTG 540
AAAACCCTGT AAGAACTTTA TGACATTGAC CAAAATGTTT GGAGAAAACA AAGGTTACAA 600
CACCATTTAT GTGTCAGCGA CCAAATGCTG TTTCCAAAAT ATTGCTGGCA TTATCACCTC 660
CCTTGCTGAC AAATATTAAC ACTTTTCAGT TTTAGATAGA GCTGGAACAG ATGGCCCTTT 720
GAGCCCCTGT TTACTGCTCT CTTTTGTGTG AAGTGGTTTC CCCTCCCACT CAGGAAAGGA 780
AAGGAAAGGT GGGAGGATGT AAACTTGAAG AATTTCCCAG CTGGAGTCCT GGGTATTAGC 840
CTGAGAGGTG ACTTATTTAT CCTACAGGAC TCCATCACAG AGGAAGGTTT TTCTGCAAGA 900
CTCTGGCTGG GCCAATCTTT ACACAATGCC TGTGAGCAGC CACAGAGTGC AGCCTTGACA 960
ATGCCACAAG CCAACTTCTG GGCCCCCCAC GATAAGCGCT GCATAGGCCT CCCTGAACCC 1020
TCACAACAGG TTCTATTATC GCCATTTCTC TGGTGAATAT GGAATAGATA GATTGAGTTA 1080
ACTTATCCCA GGTTATACAT GGAGGAGCAG GGATTCAAGC CCACGTCCAA CTGACTCCAG 1140
AACTTACAAC CAAACCAATT AATGGGATGT GTCAAGTAAT TTTCTATTTT TCCTATTTTT 1200
TGATGCTTAC ATGCACATGA AGGAAACAAG CACATTTAAT TCATAAGGCT TACAATACAT 1260
TACAAACAAA CTTAAACACC CCAGAAGGTC AGAAGTTTGC TGACCACCTA GTACCAGGGT 1320
CAGCAAACTT CCTCCATAAA AGGCATATAA ATATTTAGGC TGTGTGAGCC ACACATCTGT 1380
TTCCCAACTG TACCACAGTA GGGCAAAAGT AGCCATAGGC AACACCTAAA CAAATGGGTA 1440
TGGCTGTGCT CCAATTAAAC TTTATTTACA AAAATAGGCA GGAGGTGGGC AGGCTGCATT 1500
TAACCTCTTA GTCAAGTTTG AGAAGTTTGT GGCTGCTTGA CCTAGTGTAA AGGGCAAAGG 1560
GTTTAGAGTT AGGGAATCTA GCTTCTAACC CTGATTCTGT GCCTAAGCCA GCTGAGTGAC 1620
CTCGGGCCAA TCACTTCCCT TCTGCTTCTT CTGTAGAATT CTCTTTTCAA TTGACTGCAA 1680
AAATAAGGTA AAAATATATT TCAACATACT GAAATGTTAG CTGCAGATTC TTCATTAAAT 1740
|
